Get Access Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age.
Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age
by Jonathan Kahn
Binding: Hardcover
Author:
Number of Pages:
Amazon Page : https://www.amazon.com/Race-Bottle-Racialized-Medicine-Post-Genomic/dp/0231162987
Amazon Price : $38.59
Lowest Price :
Total Offers :
Rating: 5.0
Total Reviews: 1
Results Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age
Race in a Bottle The Story of BiDil and Racialized Race in a Bottle The Story of BiDil and Racialized Medicine in a PostGenomic Age Jonathan Kahn on FREE shipping on qualifying offers At a ceremony announcing the completion of the first draft of the human genome in 2000 President Bill Clinton declared Race in a Bottle The Story of BiDil and Racialized The story of bidil elucidates an alternative model to developing tailored therapies that promises to fill in the gap between the promise and reality of pharmacogenomic medicine It is a model that exploits race to gain regulatory and commercial advantage while ignoring its power to promote a regeneticization of racial categories in society at large Race in a Bottle The Story of BiDil and Racialized Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy bad medicine and ultimately endanger our health as a species Patricia Williams Jonathan Kahn brilliantly exposes the stunning truth behind new racebased medicines they are driven by market incentives not scientific evidence Race in a Bottle The Story of BiDil and Racialized IN THIS JOURNAL Journal Home Browse Journal Review of Jonathan Kahn Race in a Bottle The Story of Review of Jonathan Kahn Race in a Bottle The Story of BiDil and Racialized Medicine in the PostGenomic Age1 Reviewed by Nathan Nobis Morehouse College and Morehouse School of Medicine In 2005 the Food and Drug Administration FDA approved the drug BiDil a combination of two generic vasodilators hence bidil with specific indication to treat Race in a Bottle The Story of BiDil and Racialized Race in a Bottle At a ceremony announcing the completion of the first draft of the human genome in 2000 President Bill Clinton declared I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms all human beings regardless of race are more than 999 percent the same Race in a bottle the story of BiDil and racialized Stanford Libraries official online search tool for books media journals databases government documents and more Project MUSE Race in a Bottle The Story of BiDil and Race in a Bottle is at its most effective in debunking two things BiDil’s racialized indication and racialized medicine as a path toward pharmacogenomics As Kahn fastidiously shows the vasodilating drug combination that would become BiDil isosorbide dinitrate and hydralazine was originally conceived of as a treatment for anyone with Race in a Bottle Columbia University Press Race in a Bottle is absolutely essential for understanding why the myth of biological race has reemerged in genomic science and biotechnology and how it is distorting research damaging pubic health and undermining justice in our supposedly postracial society
